AgeSUD: Substance Use and Lifestyle-related Health Problems in Ageing Patients in OMT Treatment
Study Details
Study Description
Brief Summary
The overall aim of the study is to explore substance use, tobacco use and lifestyle-related health problems among ageing patients in Opioid Maintenance Treatment (OMT), and other SUD treatment.
The study will use already collected data from the multi-center, longitudinal, observational NorComt study (Norwegian Cohort of Patients in Opioid Maintenance Treatment and Other Drug Treatment study).
NorComt is the largest longitudinal study of SUD patients in Norway. The data consists of data from OMT and other substance use disorders (SUD) treatment (N=548).
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
The overall aim of the study is to explore substance use, tobacco use and lifestyle-related health problems among ageing patients in Opioid Maintenance Treatment (OMT), and other SUD treatment.
The study will use already collected data from the multi-center, longitudinal, observational NorComt study (Norwegian Cohort of Patients in Opioid Maintenance Treatment and Other Drug Treatment study).
NorComt is the largest longitudinal study of SUD patients in Norway. The data consists of data from OMT and other substance use disorders (SUD) treatment (N=548).
The present PhD-project is financed by the Southern and Eastern Norway Regional Health Authority, and hosted by Sørlandet hospital in collaboration with the Norwegian Centre for Addiction Research (SERAF).
Ethical approval for analysis of NorComt data and for the planned registry data linkages of NorComt data has been granted by the Norwegian Regional Ethics Committee (REK 2012/1131).
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Patients in OMT and other SUD treatment Patients in opioid maintenance treatment and other substance use disorder treatment |
Other: Substance use disorder treatment
The study followed a heterogenous sample of patients in opioid maintenance treatment (OMT) and other substance use disorder treatment. The main focus was on health related problems in this cohort, with focus on tobacco use and substance use.
|
Outcome Measures
Primary Outcome Measures
- Tobacco use [Approximately one year after admission to treatment (range 11 - 18 months)]
Changes in tobacco use from baseline to follow-up
- Substance use [Approximately one year after admission to treatment (range 11 - 18 months)]
Changes in substance use from baseline to follow-up. Excerpts from the EuropASI were used to collect data on substance use and a severity score was calculated according to EuropASI instructions, ranging from 0 to 1, where 1 is the highest severity.
Secondary Outcome Measures
- Mental distress [Approximately one year after admission to treatment (range 11 - 18 months)]
Changes from baseline to post-treatment and follow-up. The Hopkins Symptom Checklist (HSCL) 25-item version was used to measure mental distress. Each of the 25 items was scored on a 5-point scale (0-4). An average score was computed, indicating a global severity index of mental distress (GSI).
- QoL (quality of life) [Approximately one year after admission to treatment (range 11 - 18 months)]
Excerpts from the QoL10 will be used to assess QoL. The scale has 10 ordinal items and each item is scored from 1 = very poor up to 5 = very good. The scale is transformed to a decimal scale ranging from 0.1 to 0.9 and averaged, where 0.9 is the best QoL. A normative score in a population sample was 0.7.
Eligibility Criteria
Criteria
Inclusion Criteria:
- Admittance to a substance use disorder treatment facility, either standardized opioid maintenance treatment (OMT) or other substance use disorder treatment (in-patient)
Exclusion Criteria:
- None
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Addiction Unit - Sørlandet Hospital | Kristiansand | Agder | Norway | 4600 |
Sponsors and Collaborators
- Sorlandet Hospital HF
- University of Oslo
Investigators
- Principal Investigator: Thomas Clausen, PhD, Norwegian Centre for Addiction Research, University of Oslo
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 813485